Pathological changes in the vitreoretinal junction 1: Epiretinal membrane formation

Eye

Volumn 22, Issue 10, 2008, Pages 1310-1317

  Snead, D R J ^a   James, S ^a   Snead, M P ^b  

^a UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMOSIDERIN;

ADULT; AGE; AGED; CADAVER; CAPILLARY; CELL ISOLATION; CELL TYPE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MICROSCOPY; PIGMENT EPITHELIUM; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA TEAR; VITREORETINOPATHY; VITREOUS BODY;

EID: 54249167929     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.36     Document Type: Conference Paper

References (35)

1. Foos RY. Vitreoretmal juncture - simple epiretinal membranes. Graefes Arch Clin Exp Ophthalmol 1974; 189: 231-250.
2. Roth AM, Foos RY. Surface wrinkling retinopathy in eyes enucleated at autopsy. Trans Am Acad Ophthalmol Otolaryngol 1971; 75(5): 1047-1058.
3. Schumann RG, Schaumberger MM, Rohleder M, Haritoglou C, Kampik A, Gandorfer A. Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: A consecutive analysis of 100 cases. Am J Ophthalmol 2006; 141(6): 1112-1119.
4. Ishida S, Yamazaki K, Shinoda K, Kawashima S, Oguchi Y. Macular hole retmal detachment in highly myopic eyes: Ultrastructure of surgically removed epiretinal membrane and clinicopathologic correlation. Retina 2000; 20(2): 176-183.
5. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. Indocyanine green-assisted membrane peeling of the internal limiting membrane in macular hole surgery affects visual outcome: A clinicopathologic correlation. Am J Ophthalmol 2002; 134 (6): 836-841.
6. Blain P, Paques M, Massin P, Erginay A, Spielmann AC, Santiago PY et al. Epiretinal membranes surrounding idiopathic macular holes. Retina 1998; 18(4): 316-321.
7. Hiscott P, Hagan S, Heathcote L, Sheridan CM, Groenewald CP, Grierson I et al. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye 2002; 16(4): 393-403.
8. Sheridan CM, Magee RM, Hiscott PS, Hagan S, Wong DH, McGalliard JN et al. The role of matricellular proteins thrombospondin-1 and osteonectin during RPE cell migration in proliferative vitreoretinopathy. Curr Eye Res 2002; 25(5): 279-285.
9. Harada C, Harada T, Mitamura Y, Quah HM, Ohtsuka K, Kotake S et al Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy. Mol Vis 2004; 10: 31-36.
10. Hiscott PS, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: An immunohistochemical study. Br J Ophthalmol 1984; 68(10): 708-715.
11. Smiddy WE, Maguire AM, Green WR, Michels RG, de la Cruz Z, Enger C et al. Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathological correlation. Ophthalmology 1989; 96: 811-821.
12. McLeod D, Hiscott P, Grierson I. Age-related cellular proliferation at the vitreorefinal juncture. Eye 1987; 1: 263-281.
13. Foos RY. Vitreoretinal juncture; epiretinal membranes and vitreous. Invest Ophthalmol Vis Sci 1977; 16(5): 416-422.
14. Snead DR, Cullen N, James S, Poulson AV, Morris AH, Lukaris A et al Hyperconvolution of the inner limiting membrane in vitreomaculopathies. Graefes Arch Clin Exp Ophthalmol 2004; 242 (10): 853-862.
15. Snead M, Snead D, Mahmood A, Scott J. Vitreous detachment and the posterior hyaloid membrane: A clinicopathological study. Eye 1994; 8: 204-209.
16. Shankar P, Bradshaw SE, Ang A, Rennie IG, Snead DR, Snead MP, Vascularised epiretinal brane associated with vasoproliferative tumour. Eye 2007; 21(7): 1003-1004.
17. Addison A, Snead DR, Snead MP. Radiation retinopathy secondary to radiotherapy for a lower lid BCC. Eye 2004; 18(12): 1273-1274.
18. Green WR, Kenyon KR, Michels RG, Gilbert HD, De La Cruz Z. Ultrastructure of epiretinal membranes causing macular pucker after retinal re-attachment surgery. Trans Ophthalmol Soc UK 1979; 99 (1): 65-77.
19. Charteris DG, Downie J, Aylward GW, Sethi C, Luthert P. Intraretinal and perketinal pathology in anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 2007; 245(1): 93-100.
20. Smiddy WE, Michels RG, Green WR. Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina 1990; 10(4): 288-296.
21. Harada C, Mitamura Y, Harada T. The role of cytokines and trophic factors in epiretinal membranes: Involvement of signal transduction in glial cells. Prog Retin Eye Res 2006, 25(2): 149-164.
22. Cassidy L, Barry P, Shaw C, Duffy MJ, Kennedy S. Platelet derived growth factor and fibroblast growth factor basic in vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 1998; 82: 181-185.
23. Bochaton-Piallat ML, Kapetanios AD, Donati G, Redard M, Gabbiani G, Pournaras CJ. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 2000; 41(8): 2336-2342.
24. Hiscott PS, Unger WG, Grierson I, McLeod D. The role of inflammation in the development of epiretinal membranes. Curr Eye Res 1988; 7 (9): 877-892.
25. Caldwell RB, Bartoli M, Behzadin MA, El-Remessy AE, Al-Shabrawey M, Caldwell RW. Vascular endothelial growth factor and diabetic retinopthy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 2003; 19: 442-455.
26. Abu El-Asrar AM, Missotten L, Geboes K. Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br J Ophthalmol 2007; 91 (6): 822-826.
27. Hiscott PS, Grierson I, Trombetta CJ, Rahi AH, Marshall J, McLeod D. Retinal and epiretinal glia - an immunohistochemical study. Br J Ophthalmol 1984; 68(10): 698-707.
28. Kampik A, Green WR, Michels RG, Nase PK. Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 1980; 90(6): 797-809.
29. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000; 25 (9-10): 1439-1451.
30. Kase S, Salto W, Yokoi M, Yoshida K, Furudate N, Muramatsu M et al Expression of glutamine synthetase and cell proliferation in human idiopathic epiretmal membrane. Br J Ophthalmol 2006; 90(1): 96-98.
31. Hisatomi T, Enaida H, Sakamoto T, Kanemaru T, Kagimoto T, Yamanaka I et al. Cellular migration associated with macular hole: A new method for comprehensive bird's-eye analysis of the internal limiting membrane. Arch Ophthalmol 2006; 124(7): 1005-1011.
32. Williams GA. Relationship between macular hole size and the potential benefit of internal limiting membrane peeling. Br J Ophthalmol 2006; 90(10): 1216-1217.
33. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT. Immunolocalization of keratin polypepides in human epidermis using monoclonal antibodies. J Cell Biol 1982; 95: 580-588.
34. Snead M, Snead D, Richards A, Harrison J, Poulson A, Morris A et al Clinical, histological, and ultrastructural studies of the posterior hyaloid membrane. Eye 2002; 16: 447-453.
35. Faulborn J, Boswald S. Microproliferations in proliferative diabetic retinopathy and their relationship to the vitreous: Corresponding light and electron microscopic studies. Graefes Arch Clin Exp Ophthalmol 1985; 223: 130-138.